The 4 references without contexts in paper S. Serebrova Yu., A. Prokofiev B., M. Zhuravleva V., N. Eremenko N., С. Сереброва Ю., А. Прокофьев Б., М. Журавлева В., Н. Еременко Н. (2018) “Римские критерии IV функциональных заболеваний желудочно-кишечного тракта в оценке взаимозаменяемости лекарственных препаратов: взгляд врача - клинического фармаколога // Rome IV criteria of functional gastrointestinal diseases in evaluation of drugs interchangeability: through the eyes of a clinical pharmacologist” / spz:neicon:vedomostincesmp:y:2017:i:4:p:221-227

6
Reshetko OV, Lutsevich KA. Individual bioequivalence: concept, research and variability (a review). Pharmaceutical Chemistry Journal 2009; 43(8): 3–8 (in Russian).
(check this in PDF content)
7
Lewek P. Generic drugs: The benefits and risks of making the switch. J Fam Pract 2010; 59(11): 634–40.
(check this in PDF content)
9
Sun H, Liu D, Li Y, Tang X, Cong Y. Preparation andin vitro/in vivo characterization of enteric-coated nanoparticles loaded with the antihypertensive peptide VLPVPR. Int J Nanomedicine 2014; 9(1): 1709–16.
(check this in PDF content)
10
Chourasia MK, Jain SK. Pharmaceutical approaches to colon targeted drug delivery systems. J Pharm Pharm Sci. 2003; 6(1): 33–66.
(check this in PDF content)